Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213527
Product Number: 001
Approval Date: Aug 31, 2020
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information